XML 106 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
December 31,
202320222021
(In millions)
Cash and cash equivalents$4,848 $4,006 $4,438 
Restricted cash and cash equivalents60 42 68 
Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$4,908 $4,048 $4,506 
Schedule of Restricted Cash and Cash Equivalents The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
December 31,
202320222021
(In millions)
Cash and cash equivalents$4,848 $4,006 $4,438 
Restricted cash and cash equivalents60 42 68 
Total cash and cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$4,908 $4,048 $4,506 
Schedule of Receivables
December 31,
20232022
(In millions)
Government receivables$2,354 $1,702 
Pharmacy rebate receivables330 291 
Other420 309 
Total receivables$3,104 $2,302